Scalp psoriasis is an autoimmune condition that may be worsened by poor hygiene but isn’t caused by it A dermatologist ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Patients with low psoriasis body surface area (BSA) can have similar quality of life impacts and symptom burdens as those ...

Get Instant Summarized Text (Gist) The FDA has approved Zoryve (roflumilast) 0.3% topical foam for once-daily treatment of plaque psoriasis on the scalp and body in patients aged 12 and older ...

Credit: Arcutis. The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Roflumilast foam 0.3% is a formulation that can ...

Most people affected by psoriasis don’t pay much attention to the changes in their skin to begin with. But when the patches ...

For many people with psoriasis, there are bad hair days — and then there are really bad hair days, complete with itchy, flaking scalp psoriasis that can look as icky as it feels. Scalp ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. By week 8, patients treated with roflumilast saw ...

Anyone can develop trichodynia, although it’s more prevalent among people with existing scalp disorders like psoriasis or eczema. It’s also commonly associated with fluctuating hormones and ...